TRVI earnings: a negative outcome, -6.5%

On May 13, 2021, Trevi Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.5% in the window around the event. It had already run -13.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.